They achieved 501(k) FDA Approval for Echosolve AS in Oct 2024 which is a decision support aid in the detection of severe Aortic Stenosis They are about to lodge the application for Echo Solve HF which is for Heart Failure.
There is a separate product and FDA clearance for each structural heart condition.
You should read through the company announcements over the past year to get a clearer picture.
Hope this helps.
EIQ Price at posting:
27.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)